|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Blood Serum Levels of IL-2, IL-6, IL-8, TNF-α and IL-1β in Patients on Maintenance Hemodialysis显示文摘Cytokines 是有免疫力的反应和煽动性的反应的必要调停人。有长期的肾的失败(CRF ) 的病人通常与除了 dialyzer 膜的 bioincompatibility 与损害的肾功能和尿毒症的毒素的累积联系的有免疫力的功能的畸形介绍。在 hemodialysis (HD ) 期间会议, cytokines 主要被内毒素类型混合物在有 dialyzer 的 dialyzer 液体,补充因素和直接接触激活的单核白血球释放膜。学习包括了 15 个 CRF 病人, 36.4 吗?? | Jacek Rysz Maciej Banach Aleksandra Cialkowska-Rysz Robert Stolarek Marcin Barylski Jaroslaw Drozdz Piotr Okonski | 2006 | Cellular & Molecular Immunology2006,3,2: | 14 |
| 2 | Immunological Aspects of the Statins' Function in Patients with Heart Failure:A Report from the Annual Conference of ESC-Heart Failure 2005显示文摘The annual meeting of the Heart Failure Association of ESC in Lisbon, in June 2005, was exceptionally successful.There were many very interesting presentations and workshops with the unique title: Statins in heart failureCholesterol-lowering is not the only goal Heart failure (HF) is a progressive disease with coronary artery disease (CAD) as the most often underlying etiology. Treatment to prevent progression of heart failure has been targeted to reverse the consequences of HF and to a less extent the cause - the atherosclerotic plaque itself. On the average 50% of patients with heart failure are treated with lipid intervention. Lipid-lowering treatment with statins clearly reduces morbidity and mortality of patients with documented CAD. Since the prevalent etiology of heart failure is CAD, its prevention may reduce heart failure progression. However, recent studies suggest that pleiotropic effects of statins are more important than the influence related to their cholesterol lowering mechanism. Furthermore it is suggested that low levels of circulating lipoproteins and cholesterol may be independent predictors of impaired outcome in patients with heart failure. There are some possible explanations for this finding. High levels of cholesterol can be beneficial to heart failure patients; cholesterol-rich serum lipoproteins are able to modulate inflammatory immune function because they bind and detoxify bacterial lipopolysaccharide, a very strong stimulator of the release of proinflammatory cytokines that promote heart failure progression and death. So current recommendations strongly emphasize that the aim of treatment of HF is not to lower cholesterol. | Maciej Banach Jarostaw Drozdz Piotr Okonski Jacek Rysz | 2005 | Cellular & Molecular Immunology2005,2,6: | 7 |
| 3 | Blood serum levels of IL - 2, IL- 6, IL- 8, TNF- alpha and IL- lbeta in patients on maintenance hemodialysis显示文摘 | Rysz J Banach M Cialkowska - Rysz A | 2006 | Cell Mol Immunol2006,3,: | 1 |
| 4 | Oxidative stress in nephrology显示文摘 | Pedzik A Paradowski M Rysz J | 2010 | Pol Merkur Lekarski2010,28,163: | 1 |
| 5 | The mechanisms of atrial fibrillation in hyperthyroidism显示文摘 | Bielecka-Dabrowa A Mikhailidis DP Rysz J | | 0,,: | 1 |
| 6 | Defining the role oftrimetazidine in the treatment of cardiovasculardisorders : some insights on its role in heart failure andperipheral artery disease 显示文摘 | Chrusciel P Rysz J Banach M | 2014 | Drugs2014,74,9: | 1 |
| 7 | Occurrence and transport of tetracycline, sulfonamide, quinolone, and macrolide antibiotics in the haihe river basin, china显示文摘 | Luo Y Xu L Rysz M | 2011 | Environ Sci Technol2011,45,5: | 1 |
| 8 | Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy显示文摘 | Rysz J Banach M Stolarek RA | 2007 | J Nephrol2007,20,4: | 1 |
| 9 | Nitric oxide re- lease in the peripheral blood during hemodialysis显示文摘 | Rysz J Luciak M Kedziora J | 1997 | Kidney Int1997,51,: | 1 |
| 10 | The value of structural neuroimaging in the selection of patients for epileptic surgery显示文摘 | Rysz A Bidzinski J Golebiewski M | | 0,,2: | 1 |
| 11 | The mech anisms of atrial fibrillation in hyperthyroidism 显示文摘 | Bielecka-Dabrowa A Mikhailidis DP Rysz J | 2009 | Thyroid Res2009,2,1: | 1 |
| 12 | Trends in antibiotic resistance genes occurrence in the Haihe River, China显示文摘 | Luo Y Man D Q Rysz M | 2010 | Environmental Science & Technology2010,44,19: | 1 |
| 13 | Amplification and attenuation of tetracyclie resistance in soil bacteria: aquifer column experiments 显示文摘 | Rysz M Alvarez P J J | 2004 | Water Research2004,38,17: | 1 |
| 14 | Defining the role of trimetazidine in the treatment of cardiovascular disorders:some insights on its role in heart failure and peripheral artery disease显示文摘 | Chrusciel P Rysz J Banach M | 2014 | Drugs2014,74,9: | 1 |
| 15 | Occurrence and transport of tetracycline, sulfonamide, quinolone, and macrolide antibiotits ha the Haihe River Basin, China 显示文摘 | Luo Y Xu L Rysz M | 2011 | Environmental Science & Technology2011,45,5: | 1 |
| 16 | Occurrence and transport of tetracycline, suffonamide, quinolone, and macrolide antibiotics in the Haihe River Basin, China显示文摘 | Luo Y Xu L Q Rysz M | 2011 | Environmental Science & Technology2011,45,5: | 1 |
| 17 | Amplification and attenuation of tetracycline resistance in soil bacteria: aquifer column experiments显示文摘 | Michal Rysz Pedro J.J. Alvarez | 2004 | Water Research2004,,17: | 1 |
| 18 | Serum matrix metalloproteinases MMP-2 and MMP-9 and metal loproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy 显示文摘 | Rysz J Banach M Stolarek RA | 2007 | J Nephrolo2007,20,4: | 1 |
| 19 | Occurrence and Transport of tetracycline, sulfonamide, quinolone, and maerolide antibiotics in the Haihe River Basin, China 显示文摘 | Luo Y Xu L Rysz M | 2011 | Environmental Science and Technology2011,45,5: | 1 |
| 20 | The role of trimetazidine after a- cute myocardial infarction 显示文摘 | Banach M Rysz J Goeh A | 2008 | Curt Vase Pharmacol2008,6,4: | 1 |